XBiotech Inc. Amends 8-K Filing on Officer/Director Changes
Ticker: XBIT · Form: 8-K/A · Filed: Oct 15, 2025 · CIK: 1626878
| Field | Detail |
|---|---|
| Company | Xbiotech Inc. (XBIT) |
| Form Type | 8-K/A |
| Filed Date | Oct 15, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, amendment
Related Tickers: XBI
TL;DR
XBiotech filed an amendment to its 8-K, updating info on exec and director changes from June 24.
AI Summary
XBiotech Inc. filed an 8-K/A on October 15, 2025, to amend a previous filing regarding events that occurred on June 24, 2025. The amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Why It Matters
This filing indicates potential changes in the leadership structure or compensation of key personnel at XBiotech Inc., which could impact the company's strategic direction and governance.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings concerning officer and director changes can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- XBiotech Inc. (company) — Registrant
- June 24, 2025 (date) — Date of earliest event reported
- October 15, 2025 (date) — Date of report
FAQ
What specific events on June 24, 2025, are being amended in this 8-K/A filing?
The filing amends information related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the exact date of the original event being reported or amended?
The earliest event reported or amended occurred on June 24, 2025.
What is the filing date of this amended 8-K report?
This Form 8-K/A was filed as of October 15, 2025.
What is the primary purpose of an 8-K/A filing?
An 8-K/A filing is used to amend a previously filed Current Report on Form 8-K.
What are the key areas of information covered by this amendment?
The amendment covers changes in directors or officers, elections, appointments, and executive compensation arrangements.
Filing Stats: 419 words · 2 min read · ~1 pages · Grade level 12 · Accepted 2025-10-15 12:54:38
Filing Documents
- f8ka_101525.htm (8-K/A) — 18KB
- 0001171843-25-006441.txt ( ) — 178KB
- xbio-20250624.xsd (EX-101.SCH) — 3KB
- xbio-20250624_lab.xml (EX-101.LAB) — 33KB
- xbio-20250624_pre.xml (EX-101.PRE) — 22KB
- f8ka_101525_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 15, 2025 XBIOTECH INC. By: /s/John Simard John Simard Chief Executive Officer and President